Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain milestones are reached.
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain milestones are reached.
Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.